1. Volume 65, Issue 3, Pages 570-578 (September 2016)
Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease 
Jérôme Boursier, Julien Vergniol, Anne Guillet, Jean-Baptiste Hiriart, Adrien Lannes, Brigitte Le Bail, Sophie Michalak, Faiza Chermak, Sandrine Bertrais, Juliette Foucher, Frédéric Oberti, Maude Charbonnier, Isabelle Fouchard-Hubert, Marie-Christine Rousselet, Paul Calès, Victor de Lédinghen 
Journal of Hepatology 
Volume 65, Issue 3, Pages (September 2016)
DOI: /j.jhep
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

2. Fig. 1
Rate of patients included in the intervals of ⩾90% negative (NPV) or positive (PPV) predictive values, as a function of blood fibrosis tests or liver stiffness measurement by FibroScan (LSM). The patients in the ‘grey zone’ are those for whom NPV and PPV are <90%. Results presented are those obtained in the core group allowing for direct comparisons between fibrosis tests. NFS, NAFLD Fibrosis Score; FMNAFLD, FibroMeterNAFLD; FMV2G, FibroMeterV2G.
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

3. Fig. 2
Fibrosis classifications of FibroScan and FibroMeterV2G which give an estimation of the pathological fibrosis stage from the fibrosis test result. LSM, liver stiffness measurement by FibroScan. (This figure appears in colour on the web.)
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

4. Fig. 3
Overall survival as a function of the subgroups defined by (A) the fibrosis classification developed for liver stiffness measurement by Fibroscan (LSM) or (B) the fibrosis classification developed for FibroMeterV2G. (This figure appears in colour on the web.)
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

5. Fig. 4
Simplified fibrosis classifications for LSM and FibroMeterV2G. These classifications stratify NAFLD patients into four subgroups with significantly different prognoses. (This figure appears in colour on the web.)
Journal of Hepatology  , DOI: ( /j.jhep )
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

6. Journal of Hepatology 2016 65, 570-578DOI: (10. 1016/j. jhep. 2016. 04
Copyright © 2016 European Association for the Study of the Liver Terms and Conditions